WO2010027150A3 - New preparation of hydroxychloroquine - Google Patents
New preparation of hydroxychloroquine Download PDFInfo
- Publication number
- WO2010027150A3 WO2010027150A3 PCT/KR2009/004660 KR2009004660W WO2010027150A3 WO 2010027150 A3 WO2010027150 A3 WO 2010027150A3 KR 2009004660 W KR2009004660 W KR 2009004660W WO 2010027150 A3 WO2010027150 A3 WO 2010027150A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- hydroxychloroquine
- new preparation
- preparation
- pentadiamine
- dichloroquinoline
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
- C07D215/42—Nitrogen atoms attached in position 4
- C07D215/46—Nitrogen atoms attached in position 4 with hydrocarbon radicals, substituted by nitrogen atoms, attached to said nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
- C07D215/42—Nitrogen atoms attached in position 4
- C07D215/44—Nitrogen atoms attached in position 4 with aryl radicals attached to said nitrogen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Abstract
The present invention provides a process for the preparation of hydroxychloroquine by the reaction of 4,7-dichloroquinoline with N'-ethyl-N'-β-hydroxyethyl-1,4-pentadiamine under high pressure.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR10-2008-0088070 | 2008-09-08 | ||
| KR1020080088070A KR101115412B1 (en) | 2008-09-08 | 2008-09-08 | New preparation of hydroxychloroquine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| WO2010027150A2 WO2010027150A2 (en) | 2010-03-11 |
| WO2010027150A3 true WO2010027150A3 (en) | 2010-06-17 |
Family
ID=41797613
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/KR2009/004660 Ceased WO2010027150A2 (en) | 2008-09-08 | 2009-08-21 | New preparation of hydroxychloroquine |
Country Status (2)
| Country | Link |
|---|---|
| KR (1) | KR101115412B1 (en) |
| WO (1) | WO2010027150A2 (en) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102050781B (en) * | 2010-12-21 | 2012-07-25 | 重庆康乐制药有限公司 | Industrial preparation method of hydroxychloroquine sulfate |
| CN103724261B (en) * | 2013-12-13 | 2016-05-25 | 武汉武药制药有限公司 | A kind of industrialized process for preparing of hydroxychloroquine sulfate quinoline |
| CN104230803B (en) * | 2014-08-28 | 2017-02-01 | 重庆康乐制药有限公司 | Preparation method of hydroxychloroquine sulfate |
| WO2019165337A1 (en) * | 2018-02-26 | 2019-08-29 | Virginia Commonwealth University | High-yielding continuous flow synthesis of antimalarial drug hydroxychloroquine |
| CN108727263A (en) * | 2018-07-05 | 2018-11-02 | 上海中西三维药业有限公司 | Hydroxychloroquine sulfate crystal form A and preparation method thereof |
| CN109456266A (en) * | 2018-11-12 | 2019-03-12 | 南京天际联盟医药科技有限公司 | The novel preparation method of hydroxychloroquine sulfate |
| CN109280029A (en) * | 2018-12-11 | 2019-01-29 | 上海应用技术大学 | A kind of preparation method of hydroxychloroquine sulfate |
| CN113072491B (en) * | 2020-01-06 | 2024-06-18 | 欣凯医药化工中间体(上海)有限公司 | Preparation method of hydroxychloroquine sulfate |
| CN111551645B (en) * | 2020-04-30 | 2022-11-08 | 上海中西三维药业有限公司 | Method for detecting hydroxychloroquine sulfate related substances and application thereof |
| CN112300071B (en) * | 2020-11-25 | 2023-01-31 | 威胜生物医药(苏州)股份有限公司 | Synthetic method of high-purity chloroquine phosphate |
| CN113149904B (en) * | 2021-03-02 | 2024-07-09 | 南京海纳医药科技股份有限公司 | A method for refining hydroxychloroquine crude product |
| CN114380744A (en) * | 2021-12-22 | 2022-04-22 | 深圳市祥根生物医药有限公司 | A kind of preparation method of hydroxychloroquine sulfate impurity |
| WO2024261606A1 (en) | 2023-06-22 | 2024-12-26 | Tübi̇tak | Production process for hydroxychloroquine under concentrated conditions |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2546658A (en) * | 1949-07-23 | 1951-03-27 | Sterling Drug Inc | 7-chloro-4-[5-(n-ethyl-n-2-hydroxyethylamino)-2-pentyl] aminoquinoline, its acid addition salts, and method of preparation |
| US5314894A (en) * | 1992-09-15 | 1994-05-24 | Sterling Winthrop Inc. | (S)-(+)-hydroxychloroquine |
| WO2005062723A2 (en) * | 2003-11-24 | 2005-07-14 | Ipca Laboratories Limited | An improved process for the preparation of 7-chloro-4-(5-n-ehtyl-n-2-hydroxyethylamine)-2-pentyl] aminoquinoline and its intermediates |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2561987A1 (en) * | 2006-10-02 | 2008-04-02 | Apotex Pharmachem Inc. | Process for the preparation of highly pure hydroxychloroquine or a salt thereof |
-
2008
- 2008-09-08 KR KR1020080088070A patent/KR101115412B1/en not_active Expired - Fee Related
-
2009
- 2009-08-21 WO PCT/KR2009/004660 patent/WO2010027150A2/en not_active Ceased
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2546658A (en) * | 1949-07-23 | 1951-03-27 | Sterling Drug Inc | 7-chloro-4-[5-(n-ethyl-n-2-hydroxyethylamino)-2-pentyl] aminoquinoline, its acid addition salts, and method of preparation |
| US5314894A (en) * | 1992-09-15 | 1994-05-24 | Sterling Winthrop Inc. | (S)-(+)-hydroxychloroquine |
| WO2005062723A2 (en) * | 2003-11-24 | 2005-07-14 | Ipca Laboratories Limited | An improved process for the preparation of 7-chloro-4-(5-n-ehtyl-n-2-hydroxyethylamine)-2-pentyl] aminoquinoline and its intermediates |
Also Published As
| Publication number | Publication date |
|---|---|
| KR20100029332A (en) | 2010-03-17 |
| KR101115412B1 (en) | 2012-06-12 |
| WO2010027150A2 (en) | 2010-03-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2010027150A3 (en) | New preparation of hydroxychloroquine | |
| WO2010015657A3 (en) | Alkoxypyrazoles and the process for their preparation | |
| WO2007093627A3 (en) | Biocidal composition | |
| TW200745261A (en) | Aqueous dispersions based on nitrocellulose-polyurethane particles | |
| WO2009114438A3 (en) | Cyclohexanedimethanamine by direct amination of cyclohexanedimethanol | |
| WO2008135482A8 (en) | Ionic liquids comprising polyethercarboxylates as anions, production and use thereof | |
| MX2009008660A (en) | Method for the preparation of therapeutically valuable triphenylbutene derivatives. | |
| WO2010110599A3 (en) | Novel αlpha-neoagarobiose hydrolase, and method for obtaining a monosaccharide using same | |
| WO2010017387A3 (en) | Lapatinib, salts thereof, processes and intermediates for their preparation | |
| WO2009121501A3 (en) | Particles, obtained by drying an aqueous nanourea dispersion | |
| WO2011046303A3 (en) | Novel method for preparing entecavir and intermediate used therein | |
| WO2007132354A3 (en) | Process for preparing voriconazole, new polymorphic form of intermediate thereof, and uses thereof | |
| WO2008137050A3 (en) | A process for preparing drospirenone and intermediate thereof | |
| WO2008111096A3 (en) | Novel prodrugs | |
| TW200833649A (en) | Method for the preparation of hydroxyadamantanamine | |
| WO2010116342A8 (en) | Non-steroidal compounds for androgen receptor modulation, processes for the preparation and uses thereof | |
| WO2009000533A8 (en) | Novel herbicides | |
| MX2011007631A (en) | Aqueous polymer dispersion. | |
| WO2010015656A3 (en) | Alkoxypyrazoles and the process for their preparation | |
| WO2010039885A3 (en) | Crystalline forms of dexlansoprazole | |
| WO2010117979A3 (en) | Serotonin and norepinephrine reuptake inhibitor | |
| WO2011107967A3 (en) | Improved polymer membranes, processes for production thereof and use thereof | |
| MX2009011787A (en) | Processes for preparing (r)-2-methylpyrrolidine and (s)-2-methylpyrrolidine and tartrate salts thereof. | |
| WO2009149344A3 (en) | Solid states of aliskiren free base | |
| SG166064A1 (en) | Process for preparing substituted 1,4-quinone methides |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 09811649 Country of ref document: EP Kind code of ref document: A2 |
|
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| 122 | Ep: pct application non-entry in european phase |
Ref document number: 09811649 Country of ref document: EP Kind code of ref document: A2 |